JNJ
Johnson & Johnson
- EBITDA, FY2014
- $25.5B
- YoY, FY2014
- +24.2%
- 5-year CAGR
- +5.7%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| FY2014 | $25.5B | +24.2% |
| FY2013 | $20.5B | +10.2% |
| FY2012 | $18.6B | +10.0% |
| FY2011 | $16.9B | −18.0% |
| FY2010 | $20.6B | +6.6% |
| FY2009 | $19.4B | — |
Johnson & Johnson
| Period | EBITDA | YoY |
|---|---|---|
| FY2014 | $25.5B | +24.2% |
| FY2013 | $20.5B | +10.2% |
| FY2012 | $18.6B | +10.0% |
| FY2011 | $16.9B | −18.0% |
| FY2010 | $20.6B | +6.6% |
| FY2009 | $19.4B | — |